
STAA
STAAR Surgical Company
Company Overview
| Mkt Cap | $1.31B | Price | $28.00 |
| Volume | 2.02M | Change | +2.38% |
| P/E Ratio | -64.9 | Open | $27.51 |
| Revenue | $313.9M | Prev Close | $27.35 |
| Net Income | $-20.2M | 52W Range | $13.50 - $30.81 |
| Div Yield | N/A | Target | $25.00 |
| Overall | 70 | Value | 60 |
| Quality | -- | Technical | 81 |
No chart data available
About STAAR Surgical Company
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Latest News
BTIG Remains a Hold on Staar Surgical (STAA)
STAAR Surgical Reports Q3 2025 Financial Results
Staar Surgical Amends Merger Agreement with Alcon
Canaccord Genuity Remains a Hold on Staar Surgical (STAA)
Analysts Offer Insights on Healthcare Companies: Staar Surgical (STAA), Keros Therapeutics (KROS) and Electrocore (ECOR)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | STAA | $28.00 | +2.4% | 2.02M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |